{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:53:39Z","timestamp":1788429219126,"version":"build-2803163510"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173407"],"award-info":[{"award-number":["82173407"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273514"],"award-info":[{"award-number":["82273514"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304001"],"award-info":[{"award-number":["82304001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020732","name":"Innovative Research Team of High-Level Local Universities in Shanghai","doi-asserted-by":"publisher","award":["SHSMU-ZDCX20211002"],"award-info":[{"award-number":["SHSMU-ZDCX20211002"]}],"id":[{"id":"10.13039\/100020732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,18]]},"abstract":"<jats:p>While there have been reports on the combined use of rituximab (RTX) and intravenous immunoglobulin (IVIg) for treating refractory pemphigus, there is a lack of extensive research affirming the value of adding IVIg to the current RTX regimen. In this retrospective cohort study of 76 patients with pemphigus treated with RTX and systemic corticosteroids, RTX + IVIg resulted in similar clinical efficacy, but with a potential reduction in risk of pneumonia. This suggests that IVIg might be a valuable adjuvant for RTX to be considered in certain cases of pemphigus, more to improve safety profile than to ameliorate clinical outcomes.<\/jats:p>","DOI":"10.1093\/bjd\/ljaf449","type":"journal-article","created":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T12:49:05Z","timestamp":1762692545000},"page":"581-583","source":"Crossref","is-referenced-by-count":1,"title":["A single cycle of intravenous immunoglobulin as an adjuvant to rituximab in patients with pemphigus: a retrospective cohort study at a tertiary referral centre"],"prefix":"10.1093","volume":"194","author":[{"given":"Zheyun","family":"Fang","sequence":"first","affiliation":[{"name":"Department of Dermatology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7445-3473","authenticated-orcid":false,"given":"Huiyi","family":"Ke","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3061-9456","authenticated-orcid":false,"given":"Hailun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuman","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4745-5611","authenticated-orcid":false,"given":"Wenzhe","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"2026021806315272200_ljaf449-B1","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(19)31778-7","article-title":"Pemphigus","volume":"394","author":"Schmidt","year":"2019","journal-title":"Lancet"},{"key":"2026021806315272200_ljaf449-B2","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(17)30070-3","article-title":"First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial","volume":"389","author":"Joly","year":"2017","journal-title":"Lancet"},{"key":"2026021806315272200_ljaf449-B3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/ijd.14546","article-title":"Rituximab as an adjuvant therapy for pemphigus: experience in 61 patients from a single center with long-term follow-up","volume":"59","author":"Sharma","year":"2020","journal-title":"Int J Dermatol"},{"key":"2026021806315272200_ljaf449-B4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jaad.2015.04.038","article-title":"The role of adjuvant therapy in pemphigus: a systematic review and meta-analysis","volume":"73","author":"Atzmony","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"2026021806315272200_ljaf449-B5","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","article-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin","volume":"355","author":"Ahmed","year":"2006","journal-title":"N Engl J Med"},{"key":"2026021806315272200_ljaf449-B6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2133.2011.10658.x","article-title":"Comparison of immunological parameters in patients with pemphigus vulgaris following rituximab and IVIG therapy","volume":"166","author":"Feldman","year":"2012","journal-title":"Br J Dermatol"},{"key":"2026021806315272200_ljaf449-B7","doi-asserted-by":"crossref","first-page":"e14955","DOI":"10.1111\/ijcp.14955","article-title":"Comparison of rituximab and intravenous immunoglobulin in the treatment of autoimmune bullous diseases: real-life data from a single centre","volume":"75","author":"Huseynova Terzi","year":"2021","journal-title":"Int J Clin Pract"},{"key":"2026021806315272200_ljaf449-B8","doi-asserted-by":"crossref","first-page":"1267668","DOI":"10.3389\/fimmu.2023.1267668","article-title":"Current biologics in treatment of pemphigus foliaceus: a systematic review","volume":"14","author":"Carver","year":"2023","journal-title":"Front Immunol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljaf449\/65267408\/ljaf449.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/3\/581\/65267408\/ljaf449.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/3\/581\/65267408\/ljaf449.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T11:32:00Z","timestamp":1771414320000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/194\/3\/581\/8320258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":8,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,11,11]]},"published-print":{"date-parts":[[2026,2,18]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljaf449","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,11,11]]}}}